{"entity":{"id":"french-sarcoma-group","kind":"company","name":"French Sarcoma Group","aka":["Groupe Sarcome Français","GSF-GETO","French Sarcoma Group (GSF-GETO)"],"tldr":"The French Sarcoma Group is the national cooperative group for soft tissue and bone sarcoma trials in France; in OnCo it is the sponsor of ANGIOTAX and the group behind LMS-04 and CABONE.","summary":"The French Sarcoma Group (Groupe Sarcome Français, GSF-GETO) is the French cooperative group for sarcoma trials. Its website could not be read for this record: gsf-geto.org does not resolve and gsf-geto.fr carried only a placeholder page on 25 September 2026, so no seat or founding year is given here. In OnCo it is the recorded sponsor of ANGIOTAX (phase 2, weekly paclitaxel in angiosarcoma, reported 2008, no registry id) and the group named on LMS-04 (NCT02997358, phase 3, doxorubicin with trabectedin in leiomyosarcoma; the registry lead sponsor is Gustave Roussy) and CABONE (NCT02243605, phase 2, cabozantinib in osteosarcoma and Ewing sarcoma, run from the Centre Léon Bérard). ClinicalTrials.gov also lists it as a collaborator on the Italian Sarcoma Group's ISG-STS 1001. It has no products of its own.","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov: trials led by French Sarcoma Group","url":"https://clinicaltrials.gov/search?lead=French%20Sarcoma%20Group"},{"label":"ClinicalTrials.gov: LMS-04 (NCT02997358)","url":"https://clinicaltrials.gov/study/NCT02997358"}],"tags":["ctgov-sponsor","cooperative-group"],"related":[],"cancers":["sarcoma","angiosarcoma","vascular-tumours","leiomyosarcoma","uterine-sarcoma","extremity-soft-tissue-sarcoma","retroperitoneal-sarcoma","osteosarcoma","ewing-sarcoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["gustave-roussy","centre-leon-berard"],"pathways":[],"terms":[],"trials":["angiotax","lms-04","cabone"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo cooperative groups round (group websites, ClinicalTrials.gov v2, corpus trial records)","editedOn":"2026-09-25"},"hq":"France (seat not stated)","country":"FR","companyType":"cooperative-group","investors":[],"funding":[]},"route":"/companies/french-sarcoma-group/","neighbours":{"cancer":[{"id":"angiosarcoma","kind":"cancer","name":"Angiosarcoma","route":"/cancers/angiosarcoma/"},{"id":"ewing-sarcoma","kind":"cancer","name":"Ewing sarcoma","route":"/cancers/ewing-sarcoma/"},{"id":"leiomyosarcoma","kind":"cancer","name":"Leiomyosarcoma","route":"/cancers/leiomyosarcoma/"},{"id":"osteosarcoma","kind":"cancer","name":"Osteosarcoma","route":"/cancers/osteosarcoma/"},{"id":"retroperitoneal-sarcoma","kind":"cancer","name":"Retroperitoneal sarcoma","route":"/cancers/retroperitoneal-sarcoma/"},{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"},{"id":"extremity-soft-tissue-sarcoma","kind":"cancer","name":"Soft tissue sarcoma of the extremity (localised and advanced)","route":"/cancers/extremity-soft-tissue-sarcoma/"},{"id":"uterine-sarcoma","kind":"cancer","name":"Uterine sarcoma","route":"/cancers/uterine-sarcoma/"},{"id":"vascular-tumours","kind":"cancer","name":"Vascular tumours (angiosarcoma, epithelioid haemangioendothelioma, kaposiform haemangioendothelioma)","route":"/cancers/vascular-tumours/"}],"institution":[{"id":"centre-leon-berard","kind":"institution","name":"Centre Léon Bérard","route":"/institutions/centre-leon-berard/"},{"id":"gustave-roussy","kind":"institution","name":"Gustave Roussy","route":"/institutions/gustave-roussy/"}],"trial":[{"id":"angiotax","kind":"trial","name":"ANGIOTAX","route":"/trials/angiotax/"},{"id":"cabone","kind":"trial","name":"CABONE","route":"/trials/cabone/"},{"id":"lms-04","kind":"trial","name":"LMS-04","route":"/trials/lms-04/"}]}}